96 related articles for article (PubMed ID: 32939328)
1. Identification and validation of an excellent prognosis subtype of muscle-invasive bladder cancer patients with intratumoral CXCR5
Huang Q; Zhou Q; Zhang H; Liu Z; Zeng H; Chen Y; Qu Y; Xiong Y; Wang J; Chang Y; Xia Y; Wang Y; Liu L; Zhu Y; Xu L; Dai B; Guo J; Wang Z; Bai Q; Zhang W
Oncoimmunology; 2020 Aug; 9(1):1810489. PubMed ID: 32939328
[TBL] [Abstract][Full Text] [Related]
2. Infiltration and Polarization of Tumor-associated Macrophages Predict Prognosis and Therapeutic Benefit in Muscle-Invasive Bladder Cancer.
Sun M; Zeng H; Jin K; Liu Z; Hu B; Liu C; Yan S; Yu Y; You R; Zhang H; Chang Y; Liu L; Zhu Y; Xu J; Xu L; Wang Z
Cancer Immunol Immunother; 2022 Jun; 71(6):1497-1506. PubMed ID: 34716763
[TBL] [Abstract][Full Text] [Related]
3. Integrating molecular subtype and CD8
Li B; Jin K; Liu Z; Su X; Xu Z; Liu G; Xu J; Liu H; Chang Y; Wang Y; Zhu Y; Wang Z; Xu L; Zhang W
Cancer Immunol Immunother; 2024 Mar; 73(4):66. PubMed ID: 38430246
[TBL] [Abstract][Full Text] [Related]
4. Latency-associated peptide identifies therapeutically resistant muscle-invasive bladder cancer with poor prognosis.
Ye R; Zeng H; Liu Z; Jin K; Liu C; Yan S; Yu Y; You R; Zhang H; Chang Y; Wang Y; Liu L; Zhu Y; Xu J; Xu L; Wang Z
Cancer Immunol Immunother; 2022 Feb; 71(2):301-310. PubMed ID: 34152439
[TBL] [Abstract][Full Text] [Related]
5. Immune inactivation by neuropilin-1 predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer.
Yu Y; Zeng H; Jin K; You R; Liu Z; Zhang H; Liu C; Su X; Yan S; Chang Y; Liu L; Xu L; Xu J; Zhu Y; Wang Z
Cancer Immunol Immunother; 2022 Sep; 71(9):2117-2126. PubMed ID: 35041031
[TBL] [Abstract][Full Text] [Related]
6. CD19
Jiang Q; Fu Q; Chang Y; Liu Z; Zhang J; Xu L; Zhu Y; Wang Y; Zhang W; Xu J
Cancer Immunol Immunother; 2019 Jan; 68(1):45-56. PubMed ID: 30259082
[TBL] [Abstract][Full Text] [Related]
7. Single-cell sequencing reveals the heterogeneity of B cells and tertiary lymphoid structures in muscle-invasive bladder cancer.
Yuan H; Mao X; Yan Y; Huang R; Zhang Q; Zeng Y; Bao M; Dai Y; Fang B; Mi J; Xie Y; Wang X; Zhang H; Mo Z; Yang R
J Transl Med; 2024 Jan; 22(1):48. PubMed ID: 38216927
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response.
Qi Y; Chang Y; Wang Z; Chen L; Kong Y; Zhang P; Liu Z; Zhou Q; Chen Y; Wang J; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Dai B; Guo J; Wang Y; Xu J; Zhang W
Cancer Immunol Immunother; 2019 Dec; 68(12):2067-2080. PubMed ID: 31720813
[TBL] [Abstract][Full Text] [Related]
9. CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer.
Wang T; Zhou Q; Zeng H; Zhang H; Liu Z; Shao J; Wang Z; Xiong Y; Wang J; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Xu L; Dai B; Guo J; Chang Y; Wang X; Xu J
Cancer Immunol Immunother; 2020 Sep; 69(9):1855-1867. PubMed ID: 32367308
[TBL] [Abstract][Full Text] [Related]
10. Integration of CD4
Liu G; Jin K; Liu Z; Su X; Xu Z; Li B; Xu J; Liu H; Chang Y; Zhu Y; Xu L; Wang Z; Wang Y; Zhang W
Cancer Sci; 2024 Apr; 115(4):1306-1316. PubMed ID: 38402640
[TBL] [Abstract][Full Text] [Related]
11. Tumor-infiltrating neutrophils predict benefit from adjuvant chemotherapy in patients with muscle invasive bladder cancer.
Zhou L; Xu L; Chen L; Fu Q; Liu Z; Chang Y; Lin Z; Xu J
Oncoimmunology; 2017; 6(4):e1293211. PubMed ID: 28507798
[TBL] [Abstract][Full Text] [Related]
12. Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer.
Smith V; Mukherjee D; Tsakiroglou AM; Baker A; Mistry H; Choudhury A; Hoskin P; Illidge T; West CML
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612036
[TBL] [Abstract][Full Text] [Related]
13. Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening.
Rinaldetti S; Rempel E; Worst TS; Eckstein M; Steidler A; Weiss CA; Bolenz C; Hartmann A; Erben P
Oncotarget; 2018 May; 9(40):25935-25945. PubMed ID: 29899832
[TBL] [Abstract][Full Text] [Related]
14. The Antitumor Effects of Plasma-Activated Saline on Muscle-Invasive Bladder Cancer Cells In Vitro and In Vivo Demonstrate Its Feasibility as a Potential Therapeutic Approach.
Zhang H; Zhang J; Guo B; Chen H; Xu D; Kong MG
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33801297
[TBL] [Abstract][Full Text] [Related]
15. Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer.
Totonji S; Ramos-Triguero A; Willmann D; Sum M; Urban S; Bauer H; Rieder A; Wang S; Greschik H; Metzger E; Schüle R
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672614
[TBL] [Abstract][Full Text] [Related]
16. Artificial Intelligence Reveals Distinct Prognostic Subgroups of Muscle-Invasive Bladder Cancer on Histology Images.
Eminaga O; Leyh-Bannurah SR; Shariat SF; Krabbe LM; Lau H; Xing L; Abbas M
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894365
[TBL] [Abstract][Full Text] [Related]
17. A commentary on "Single-cell and bulk RNA-sequence identified fibroblasts signature and CD8+ T cell - Fibroblast subtype predicting prognosis and immune therapeutic response of bladder cancer, based on machine-learning" (Int J Surg. 2024 May 17.).
Wang Z; Zhang G; Liu X; Tan G
Int J Surg; 2024 Jun; ():. PubMed ID: 38840324
[No Abstract] [Full Text] [Related]
18. Correction to: Identification of the molecular subtype and prognostic characteristics of pancreatic cancer based on CD8 + T cell-related genes.
Xu D; Wang Y; Chen Y; Zheng J
Cancer Immunol Immunother; 2023 Mar; 72(3):665. PubMed ID: 36138159
[No Abstract] [Full Text] [Related]
19. Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival.
Chen RL; Zhou JX; Cao Y; Sun LL; Su S; Deng XJ; Lin JT; Xiao ZW; Chen ZZ; Wang SY; Lin LZ
Front Immunol; 2020; 11():1933. PubMed ID: 33072067
[TBL] [Abstract][Full Text] [Related]
20. Exploring prognostic indicators in the pathological images of hepatocellular carcinoma based on deep learning.
Shi JY; Wang X; Ding GY; Dong Z; Han J; Guan Z; Ma LJ; Zheng Y; Zhang L; Yu GZ; Wang XY; Ding ZB; Ke AW; Yang H; Wang L; Ai L; Cao Y; Zhou J; Fan J; Liu X; Gao Q
Gut; 2021 May; 70(5):951-961. PubMed ID: 32998878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
